As FGFR3 mutations are more common in low grade and stage bladder tumours, and are an early change during urothelial transformation, it is likely that besides favouring EMT in more advanced tumours, ETV5 may modulate other classes of genes in early neoplastic lesions. Here, FGFR3 is linked to neoplasm.